Australian Clinical Labs Ltd
ASX:ACL
Australian Clinical Labs Ltd
ASX:ACL
Price:
2.44 AUD
1.24%
Market Closed
Updated:
May 4, 2024
Income Statement
Earnings Waterfall
Australian Clinical Labs Ltd
Australian Clinical Labs Ltd
|
Revenue
|
697.1m
AUD
|
|
Cost of Revenue
|
-126.1m
AUD
|
|
Gross Profit
|
571m
AUD
|
|
Operating Expenses
|
-506.3m
AUD
|
|
Operating Income
|
64.7m
AUD
|
|
Other Expenses
|
-28.8m
AUD
|
|
Net Income
|
35.9m
AUD
|
Income Statement
Australian Clinical Labs Ltd
Australian Clinical Labs Ltd
Currency: AUD
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue |
647
N/A
|
867
+34%
|
996
+15%
|
818
-18%
|
697
-15%
|
|
| Gross Profit | ||||||
| Cost of Revenue |
(120)
|
(158)
|
(208)
|
(177)
|
(126)
|
|
| Gross Profit |
527
N/A
|
709
+34%
|
788
+11%
|
641
-19%
|
571
-11%
|
|
| Operating Income | ||||||
| Operating Expenses |
(399)
|
(449)
|
(514)
|
(519)
|
(506)
|
|
| Selling, General & Administrative |
(271)
|
(314)
|
(339)
|
(340)
|
(328)
|
|
| Depreciation & Amortization |
(88)
|
(94)
|
(106)
|
(119)
|
(123)
|
|
| Other Operating Expenses |
(40)
|
(41)
|
(69)
|
(60)
|
(56)
|
|
| Operating Income |
128
N/A
|
260
+103%
|
274
+5%
|
122
-55%
|
65
-47%
|
|
| Pre-Tax Income | ||||||
| Interest Income Expense |
(15)
|
(15)
|
(12)
|
(12)
|
(13)
|
|
| Non-Reccuring Items |
(19)
|
(49)
|
(7)
|
(8)
|
(3)
|
|
| Total Other Income |
(7)
|
(6)
|
0
|
0
|
(0)
|
|
| Pre-Tax Income |
87
N/A
|
190
+120%
|
255
+34%
|
103
-60%
|
48
-53%
|
|
| Net Income | ||||||
| Tax Provision |
(26)
|
(57)
|
(76)
|
(29)
|
(12)
|
|
| Income from Continuing Operations |
60
|
134
|
178
|
74
|
36
|
|
| Income to Minority Interest |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Income (Common) |
60
N/A
|
134
+121%
|
178
+34%
|
73
-59%
|
36
-51%
|
|
| EPS (Diluted) |
0.3
N/A
|
0.67
+123%
|
0.88
+31%
|
0.37
-58%
|
0.18
-51%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
